KIB OpenIR  > 共享文献
Leiocyclocin C and D, two cyclopeptides from Goniothalamus leiocarpus
Q. Mu; R. W. Teng; C. M. Li; D. Z. Wang; Y. Wu; H. D. Sun; C. Q. Hu
2003-10-01
Source PublicationPHARMAZIE
Volume58Issue:10Pages:756-758
AbstractTwo new cyclopeptides, leiocyclocin C (1) and D (2), were isolated from the seeds of Goniothalamus leiocarpus (Annonaceae). Their structures were determined as cyclo-(Gly(1)-Ser-Pro(2)-Tyr(2)-Gly(2)-Tyr(1)-Pro(1)-Pro(3)) and cyclo-(Gly(1)-Leu-Pro(1)-Gly(2)-Phe-Tyr-Pro(2)), respectively, by means of spectral and chemical methods.
Indexed BySCI ; IC
Language英语
WOS Research AreaPharmacology & Pharmacy ; Chemistry
WOS SubjectChemistry, Medicinal ; Chemistry, Multidisciplinary ; Pharmacology & Pharmacy
WOS IDWOS:000186193400016
Citation statistics
Cited Times:3[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.kib.ac.cn/handle/151853/17386
Collection共享文献
Recommended Citation
GB/T 7714
Q. Mu,R. W. Teng,C. M. Li,et al. Leiocyclocin C and D, two cyclopeptides from Goniothalamus leiocarpus[J]. PHARMAZIE,2003,58(10):756-758.
APA Q. Mu.,R. W. Teng.,C. M. Li.,D. Z. Wang.,Y. Wu.,...&C. Q. Hu.(2003).Leiocyclocin C and D, two cyclopeptides from Goniothalamus leiocarpus.PHARMAZIE,58(10),756-758.
MLA Q. Mu,et al."Leiocyclocin C and D, two cyclopeptides from Goniothalamus leiocarpus".PHARMAZIE 58.10(2003):756-758.
Files in This Item:
File Name/Size DocType Version Access License
s16.pdf(99KB)期刊论文作者接受稿限制开放CC BY-NC-SAApplication Full Text
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Q. Mu]'s Articles
[R. W. Teng]'s Articles
[C. M. Li]'s Articles
Baidu academic
Similar articles in Baidu academic
[Q. Mu]'s Articles
[R. W. Teng]'s Articles
[C. M. Li]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Q. Mu]'s Articles
[R. W. Teng]'s Articles
[C. M. Li]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.